Our results suggest an important functional axis of DCIR/ROS/CaMKII in mast cells that may represent an IgE-independent pathway, but the axis participates in regulating IgE-mediated allergen-induced mast cell activation and skin inflammation in AD, thereby highlighting the therapeutic potential for patients with AD. Here, IGHE is linked to dermatitis.